The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
December 6th 2024
A look into how SGLT2 inhibitors, GLP-1 RAs, and nsMRAs have redefined the management of cardio-kidney-metabolic diseases.
November 26th 2024
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Diabetes Dialogue: EASD 2022 and CGM News
October 13th 2022In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of Diabetes 2022 annual meeting, new data from the FLASH-UK trial, the global launch of Dexcom G7, and the announcement of US availability for the FreeStyle Libre 3.
Flash Glucose Monitoring Can Improve Glycemic Control, Time in Range in Type 1 Diabetes
October 10th 2022Data from the FLASH-UK trial, which compared FreeStyle Libre 2 against usual care for glycemic control in type 1 diabetes, provide evidence demonstrating improved glycemic control and time in target glucose range among users of the FreeStyle Libre 2 system.
American Diabetes Association, EASD Publish Joint Consensus Report on Automated Insulin Delivery
October 7th 2022Released on October 6, the joint consensus report from the ADA and EASD provides an overview of the benefits and safety concerns related to AID systems as well as offering a multitude of evidence-based recommendations on the subject.
The Endocrine Society Releases New Guidance for Telehealth Use
October 5th 2022On October 4, the Endocrine Society announced the release of a 10-page policy perspective outlining guidance related to optimal use of telehealth in endocrine care, which was composed by a 9-member panel led by Varsha G. Vimalananda, MD, MPH.
Dexcom Announces Global Launch of Dexcom G7 Glucose Monitoring System
October 4th 2022Dexcom announced their Dexcom G7 CGM system is now available for people aged 2 years or older in the UK, Ireland, Germany, Austria, and Hong Kong beginning on October 4, with plans for a rollout in New Zealand and South Africa.
Diabetes Dialogue: September 2022
September 28th 2022In this regularly scheduled September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide their own perspective on DIY looping based on the results of a recent study published in the New England Journal of Medicine and also break down a new set of consensus recommendations for the use of automated insulin delivery (AID) systems in clinical practice published in Endocrine Reviews, which Isaacs helped compose as a member of the writing committee.
Endocrine Case Report: Foot Pain
September 26th 2022Our latest endocrine case report from Brady Pregerson, MD, features a person in their mid-70s with a history of obesity, hypertension, osteoporosis, and prior ankle surgery presenting to urgent care with right lateral foot pain ongoing for about 10 days. Can you determine the correct diagnosis?
Endocrine Month in Review: September 2022
September 25th 2022Our endocrinology month in review spotlights the most popular content from the past month. Our top content from September 2022 includes new guideline recommendations from the ADA/EASD, new data on semaglutide 2.4 mg and tirzepatide, a label update for finerenone, & more!
Cybersecurity Risk with MiniMed 600 Systems Prompts Alert from FDA, Medtronic
September 20th 2022Announced on September 20, the alerts from the FDA and Medtronic notify users of a potential cybersecurity risk identified through internal testing at Medtronic that would allow unauthorized users to the pump's communication protocol, which could allow unauthorized boluses.
Benefits of Bariatric Surgery in Adolescents Endure Beyond a Decade, Study Shows
September 20th 2022An analysis of nearly 15 years of follow-up data from 97 patients who underwent bariatric surgery during adolescence provides insight into the benefits of surgery on weight loss and comorbidities among those with severe obesity.
FDA Updates Finerenone Label to Reflect Cardiovascular Outcomes Data
September 8th 2022On September 1, Bayer announced the US FDA had approved a label update for finerenone (Kerendia), which received initial approval in July 2021 for chronic kidney disease associated with type 2 diabetes, to include cardiovascular outcomes data from the FIGARO-DKD trial.
Preconception Thyroid Function Can Predict Delayed Time to Pregnancy, Risk of Spontaneous Abortion
September 2nd 2022An analysis of more than 11 million women in China details associations between preconception thyroid dysfunction, measured as thyrotropin levels, and delayed time to pregnancy and risk of spontaneous abortion.
In Type 1 Diabetes, Glycemic Control in Adolescence Can Stave Off Neurological Damage
September 1st 2022An analysis assessing the benefits of hybrid closed loop systems in patients with T1D has returned results suggesting improved glycemic control could help preserve neurological function among adolescents with type 1 diabetes.